Zoetis

ZTS NYSE
125.37
+1.69
+1.37%
After Hours: 125.83 +0.46 +0.37% 18:37 08/16 EDT
Open
124.32
Prev Close
123.68
High
125.60
Low
123.97
Volume
1.21M
Avg Vol (3M)
1.98M
52 Week High
125.88
52 Week Low
78.90
% Turnover
4.97%
Market Cap
3.05B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Zoetis ZTS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.
MORE >

Recently

Name
Price
%Change